ALLIED (ALID) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 32 95 sessions, December 27, 2024 to December 29, 2025
- Largest daily move
- +117.6% close of September 8, 2025
- 1-year change
- -98.7% closing prices, December 27, 2024 to December 29, 2025
- 1-month change
- -95.5% closing prices, November 24, 2025 to December 29, 2025
Company Description
ALLIED (OTC: ALID) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.3M.
ALID has declined 98.7% over the past year. The last closing price was $0.0005.
For FY2024, ALLIED reported revenue of $96K with net income of -$4.0M and diluted earnings per share of -$0.04.
This page collects what Stock Titan holds for ALID, including price data, latest news, and financial highlights.
Stock Performance
ALLIED (ALID) closed at $0.0005 on December 29, 2025. Over the past 12 months, the price has lost 98.7%.
ALID Metrics & Rankings
Price returns through December 29, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ALLIED has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. View all ALID news →
SEC Filings
Financial Highlights
ALLIED generated $96K in revenue in FY2024, operating income reached -$4.0M, and net income was -$4.0M. Diluted earnings per share stood at -$0.04. The company generated -$2.0M in operating cash flow. The current ratio was 0.07, measuring current assets divided by current liabilities.
Upcoming Events
ALID Company Profile & Sector Positioning
ALLIED (ALID) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ALID often look at related companies in the same sector, including PANACEA LIFE SCIENCE HLD (PLSH), ACURA PHARMS INC (ACUR), CBD LIFE SCIENCES INC (CBDL), GENIX PHARMACEUTICALS CP (GENPF), and OVATION SCIENCE INC (OVATF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ALID's relative position within its industry.